Tsang-Wu Liu
Taiwan Cooperative Oncology Group, NHRI
5
0
1
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ajay Goel, PhD
City of Hope Medical Center
Shared therapeutic areas:
Ying-Chun Shen
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
yuankai shi, MD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
Eliot Epner, MD
Penn State Hershey Cancer Institute
Shared therapeutic areas:
Maria Delioukina, MD
City of Hope National Medical Center, USA
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Xiuli Zuo, MD,PhD
Qilu Hospital of Shandong University
Shared therapeutic areas:
Saleh K Saleh, MD
Minia University
Shared therapeutic areas:
Peng Wang, MD
Fudan University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas
BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)
Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy
All 5 trials loaded